#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	13820	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2097	653.9	0	.	n	.	0	C1450T	SNP	1450	1450	C	1682	1682	T	773	T	698	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	13820	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2097	653.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1416	1416	C	866	C	793	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24892	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3569	693.3	0	.	n	.	0	G1337A	SNP	1337	1337	G	1580	1580	A	869	A	811	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24892	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3569	693.3	0	.	n	.	0	T1971C	SNP	1971	1971	T	2214	2214	C	795	C	730	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24892	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3569	693.3	1	SNP	n	A2045G	0	.	.	2045	2045	A	2288	2288	A	800	A	735	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24892	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3569	693.3	1	SNP	n	C2597T	0	.	.	2597	2597	C	2840	2840	C	751	C	695	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24892	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3569	693.3	0	HET	.	.	.	C1287T	.	1287	1287	C	1530	1530	C	829	C,T	489,233	.	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	27	38420	blaTEM	861	861	100.0	blaTEM.l6.c4.ctg.1	1510	2530.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Betalactam resistance
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	1854	folP	855	855	99.88	folP.l15.c17.ctg.1	1443	127.4	1	SNP	p	R229S	1	.	.	685	687	AGC	951	953	AGC	203;202;202	A;G;C	189;190;186	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_G_01105	gyrA.WHO_G_01105	1	1	539	4850	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3260	148.1	0	.	p	.	0	D95A	NONSYN	283	285	GAC	565	567	GCC	173;168;168	G;C;C	151;148;147	.	.
gyrA.WHO_G_01105	gyrA.WHO_G_01105	1	1	539	4850	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3260	148.1	1	SNP	p	S91F	1	.	.	271	273	TTC	553	555	TTC	167;171;175	T;T;C	149;153;152	gyrA.WHO_G_01105:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	531	1396	mtrR	633	633	99.06	mtrR.l6.c30.ctg.1	1316	105.5	0	.	p	.	0	A39T	NONSYN	115	117	GCC	460	462	ACC	177;178;179	A;C,A;C	160;165,1;165	.	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	531	1396	mtrR	633	633	99.06	mtrR.l6.c30.ctg.1	1316	105.5	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	658	660	CAC	174;175;174	C;A;C	162;162;161	.	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	531	1396	mtrR	633	633	99.06	mtrR.l6.c30.ctg.1	1316	105.5	0	.	p	.	0	A127fs	FSHIFT	379	379	G	724	724	G	159	G	144	.	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	531	1396	mtrR	633	633	99.06	mtrR.l6.c30.ctg.1	1316	105.5	1	SNP	p	G45D	0	.	.	133	135	GGC	478	480	GGC	189;187;190	G;G;C	174;170;171	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	822	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	955	85.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4270	parC	2304	2304	99.87	parC.l6.c4.ctg.1	3202	132.7	0	.	p	.	0	I384V	NONSYN	1150	1152	ATC	1694	1696	GTC	158;158;162	G;T;C	144;140;146	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4270	parC	2304	2304	99.87	parC.l6.c4.ctg.1	3202	132.7	1	SNP	p	D86N	0	.	.	256	258	GAC	800	802	GAC	165;169;168	G;A;C	149;149;152	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4270	parC	2304	2304	99.87	parC.l6.c4.ctg.1	3202	132.7	1	SNP	p	R87I	0	.	.	259	261	CGT	803	805	CGT	169;172;173	C;G;T	152;154;154	parC.WHO_V_00204c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4270	parC	2304	2304	99.87	parC.l6.c4.ctg.1	3202	132.7	1	SNP	p	S87R	1	.	.	259	261	CGT	803	805	CGT	169;172;173	C;G;T	152;154;154	parC.WHO_V_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4270	parC	2304	2304	99.87	parC.l6.c4.ctg.1	3202	132.7	1	SNP	p	R87W	0	.	.	259	261	CGT	803	805	CGT	169;172;173	C;G;T	152;154;154	parC.WHO_V_00204c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4270	parC	2304	2304	99.87	parC.l6.c4.ctg.1	3202	132.7	1	SNP	p	S88P	0	.	.	262	264	TCC	806	808	TCC	174;174;175	T;C;C	154;156;159	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3992	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2514	157.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1512	1514	GGC	204;206;206	G;G;C	181;182;179	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.19.001	penA.19.001	1	1	27	3914	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2402	161.9	1	SNP	p	A311V	0	.	.	931	933	GCA	1286	1288	GCA	196;198;198	G,A;C;A	176,1;176;178	penA.19.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3914	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2402	161.9	1	SNP	p	I312M	0	.	.	934	936	ATC	1289	1291	ATC	196;196;195	A;T;C	175;176;176	penA.19.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3914	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2402	161.9	1	SNP	p	V316T	0	.	.	946	948	GTG	1301	1303	GTG	196;195;195	G;T;G	176;176;176	penA.19.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3914	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2402	161.9	1	SNP	p	V316P	0	.	.	946	948	GTG	1301	1303	GTG	196;195;195	G;T;G	176;176;176	penA.19.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3914	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2402	161.9	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1805	1807	ACC	215;214;213	A;C;C	182;188;188	penA.19.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3914	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2402	161.9	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1859	1861	GCG	186;187;187	G;C;G	165;155;158	penA.19.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3914	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2402	161.9	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1859	1861	GCG	186;187;187	G;C;G	165;155;158	penA.19.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3914	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2402	161.9	1	SNP	p	G543S	0	.	.	1627	1629	GGT	1982	1984	GGT	181;183;181	G;G;T	171;173;169	penA.19.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3914	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2402	161.9	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1991	1993	GGC	181;177;176	G;G;C	165;159;158	penA.19.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3914	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2402	161.9	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2009	2011	CCG	155;156;158	C,G;C,G;G	98,2;107,1;103	penA.19.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5440	ponA	2397	2397	100.0	ponA.l15.c30.ctg.1	3147	171.9	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1641	1643	CCG	181;179;181	C;C;G	163;162;164	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1936	porA	1146	1146	99.65	porA.l15.c30.ctg.1	1588	120.6	0	.	p	.	0	M83fs	FSHIFT	247	247	A	476	476	C	140	C	123	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2774	porB1b	1035	1035	98.94	porB1b.l15.c4.ctg.1	1451	188.9	0	.	p	.	0	R143G	NONSYN	427	429	AGA	692	694	GGA	223;226;227	G;G;A	211;215;211	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2774	porB1b	1035	1035	98.94	porB1b.l15.c4.ctg.1	1451	188.9	0	.	p	.	0	.	INDELS	629	630	AA	895	897	TAG	225;225;221	T;A;G	203;203;198	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2774	porB1b	1035	1035	98.94	porB1b.l15.c4.ctg.1	1451	188.9	0	.	p	.	0	.	MULTIPLE	631	633	TAC	899	902	CAAT	219;220;219;219	C;A,C;A;T	195;194,1;194;194	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2774	porB1b	1035	1035	98.94	porB1b.l15.c4.ctg.1	1451	188.9	0	.	p	.	0	N212fs	FSHIFT	634	634	A	904	904	T	216	T	191	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2774	porB1b	1035	1035	98.94	porB1b.l15.c4.ctg.1	1451	188.9	1	SNP	p	G120K	0	.	.	358	360	GGT	623	625	GGT	255;253;251	G;G;T,C	228;227;220,1	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2774	porB1b	1035	1035	98.94	porB1b.l15.c4.ctg.1	1451	188.9	1	SNP	p	A121N	0	.	.	361	363	GCC	626	628	GCC	248;244;246	G;C;C	223;223;224	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2774	porB1b	1035	1035	98.94	porB1b.l15.c4.ctg.1	1451	188.9	1	SNP	p	A121D	0	.	.	361	363	GCC	626	628	GCC	248;244;246	G;C;C	223;223;224	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11014	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4774	229.2	1	SNP	p	H553N	1	.	.	1657	1659	AAT	1979	1981	AAT	277;275;276	A;A;T	248;246;245	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1158	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	983	117.1	1	SNP	p	V57M	1	.	.	169	171	ATG	535	537	ATG	247;246;247	A;T;G	231;229;228	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11130	tetM	1920	1920	96.3	tetM.l6.c17.ctg.1	2566	432.1	0	.	p	.	0	M177T	NONSYN	529	531	ATG	876	878	ACG	434;434;430	A;C;G	416;418;415	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11130	tetM	1920	1920	96.3	tetM.l6.c17.ctg.1	2566	432.1	0	.	p	.	0	Y184D	NONSYN	550	552	TAC	897	899	GAC	362;357;358	G;A;C	358;351;355	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11130	tetM	1920	1920	96.3	tetM.l6.c17.ctg.1	2566	432.1	0	.	p	.	0	T190M	NONSYN	568	570	ACG	915	917	ATG	340;341;336	A;T;G	338;338;335	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11130	tetM	1920	1920	96.3	tetM.l6.c17.ctg.1	2566	432.1	0	.	p	.	0	L194S	NONSYN	580	582	TTA	927	929	TCA	333;330;330	T;C;A	331;328;329	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11130	tetM	1920	1920	96.3	tetM.l6.c17.ctg.1	2566	432.1	0	.	p	.	0	H209Q	NONSYN	625	627	CAT	972	974	CAG	352;355;359	C,G;A;G	343,1;346;351	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11130	tetM	1920	1920	96.3	tetM.l6.c17.ctg.1	2566	432.1	0	.	p	.	0	V216L	NONSYN	646	648	GTT	993	995	CTT	362;360;363	C;T;T	355;354;358	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11130	tetM	1920	1920	96.3	tetM.l6.c17.ctg.1	2566	432.1	0	.	p	.	0	N223S	NONSYN	667	669	AAC	1014	1016	AGT	377;378;380	A;G;T	368;367;366	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11130	tetM	1920	1920	96.3	tetM.l6.c17.ctg.1	2566	432.1	0	.	p	.	0	Q246P	NONSYN	736	738	CAG	1083	1085	CCG	543;549;554	C,A;C,T;G	496,1;501,1;509	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11130	tetM	1920	1920	96.3	tetM.l6.c17.ctg.1	2566	432.1	0	.	p	.	0	P280S	NONSYN	838	840	CCG	1185	1187	TCG	649;646;639	T;C;G	585;578;575	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11130	tetM	1920	1920	96.3	tetM.l6.c17.ctg.1	2566	432.1	0	.	p	.	0	E337K	NONSYN	1009	1011	GAG	1356	1358	AAA	310;307;306	A,T;A;A	295,1;293;293	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11130	tetM	1920	1920	96.3	tetM.l6.c17.ctg.1	2566	432.1	0	.	p	.	0	R338K	NONSYN	1012	1014	AGA	1359	1361	AAG	299;291;283	A;A;G	288;282;274	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11130	tetM	1920	1920	96.3	tetM.l6.c17.ctg.1	2566	432.1	0	.	p	.	0	L343H	NONSYN	1027	1029	CTC	1374	1376	CAC	253;252;250	C;A;C	251;243;248	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11130	tetM	1920	1920	96.3	tetM.l6.c17.ctg.1	2566	432.1	0	.	p	.	0	Q356E	NONSYN	1066	1068	CAA	1413	1415	GAA	221;221;224	G;A;A	219;220;224	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11130	tetM	1920	1920	96.3	tetM.l6.c17.ctg.1	2566	432.1	0	.	p	.	0	A382T	NONSYN	1144	1146	GCG	1491	1493	ACG	164;164;164	A;C;G	161;164;163	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11130	tetM	1920	1920	96.3	tetM.l6.c17.ctg.1	2566	432.1	0	.	p	.	0	T399I	NONSYN	1195	1197	ACT	1542	1544	ATT	254;252;253	A;T;T	227;227;228	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11130	tetM	1920	1920	96.3	tetM.l6.c17.ctg.1	2566	432.1	0	.	p	.	0	C400S	NONSYN	1198	1200	TGT	1545	1547	AGT	252;253;253	A;G;T	228;232;227	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11130	tetM	1920	1920	96.3	tetM.l6.c17.ctg.1	2566	432.1	0	.	p	.	0	I413L	NONSYN	1237	1239	ATA	1584	1586	CTA	289;293;295	C;T;A	266;270;271	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11130	tetM	1920	1920	96.3	tetM.l6.c17.ctg.1	2566	432.1	0	.	p	.	0	K427N	NONSYN	1279	1281	AAA	1626	1628	AAT	199;200;200	A;A;T,A	192;191;191,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11130	tetM	1920	1920	96.3	tetM.l6.c17.ctg.1	2566	432.1	0	.	p	.	0	A450S	NONSYN	1348	1350	GCA	1695	1697	TCA	301;302;307	T;C;A	288;290;288	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11130	tetM	1920	1920	96.3	tetM.l6.c17.ctg.1	2566	432.1	0	.	p	.	0	V458M	NONSYN	1372	1374	GTA	1719	1721	ATG	340;338;339	A;T;G	325;321;324	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11130	tetM	1920	1920	96.3	tetM.l6.c17.ctg.1	2566	432.1	0	.	p	.	0	N556T	NONSYN	1666	1668	AAC	2013	2015	ACC	635;628;625	A,C;C,A;C	590,1;589,1;586	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11130	tetM	1920	1920	96.3	tetM.l6.c17.ctg.1	2566	432.1	0	.	p	.	0	K588E	NONSYN	1762	1764	AAA	2109	2111	GAA	612;616;614	G;A;A	566;569;569	.	Tetracycline resistance
